Update: Correction to Erroneous ‘All Trade Average

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Update: Correction to Erroneous ‘All Trade Average Prices’ for Danish Bonds

Update: Correction to Erroneous ‘All Trade Average Prices’ for Danish Bonds

Dear customer,

NASDAQ OMX has detected an error related to calculation of average prices on Danish Bonds. As a consequence of erroneous handling of flag settings for reported trades (introduced in GCF Production from 4th of April) cancellation of reported trades were disregarded when calculating the AllTradesAverage.

The error has been corrected and the system will calculate correctly starting from 9th April, 2014.

Attached file include the corrected prices for 4th and 7th of April. The correct prices for 8th April will be distributed after market close today.

If you have any questions please contact Technical Support, phone +46 8 405 6750.

ISIN ID SYMBOL TRADING DATE AVG PRICE PROD AVG PRICE CORRECT
DK0009371502 578280 2BRF321E15 20140404 101,631 101,583
DK0009789653 1120546 2NYKE A34 20140404 94,775 94,744
DK0009784852 951936 2NYKHBok14nc 20140404 101,146 100,890
DK0009286585 988518 2RD10TAP18 20140404 104,509 104,517
DK0009287203 988538 2RD10TJA15 20140404 101,383 101,321
DK0009287203 1063776 2RD10TJA15 EB 20140404 101,383 101,321
DK0009289258 1090290 3,5RDSDROOA44 20140404 100,334 100,334
DK0003427854 448902 4%Oerestad15 20140404 103,533 103,525
DK0009757296 4829 4NYK03D 35 20140404 106,113 106,169
DK0009757296 73361 4NYK03D 35 EB 20140404 106,113 106,169
LU0395694267 459748 5RD10QLU 16 20140404 108,520 108,515
DK0009245201 3978 9KD 23a 22 20140404 119,352 117,983
DK0030330907 1493634 DB C F 2019 20140404 101,525 100,300
DK0009788929 1128392 2NYKGBap17nc 20140407 103,843 103,843
DK0009783292 952008 2NYKHBja17nc 20140407 103,340 104,094
DK0009787368 1026932 3,5NYKE A44 20140407 101,814 101,805
DK0009787368 1063830 3,5NYKE A44 EB 20140407 101,814 101,805
DK0009787442 1084270 3,5NYKE DA44 20140407 100,588 100,594
DK0009288441 1026748 3,5RDSDRO23S44 20140407 101,808 101,797
DK0009288441 1063524 3,5RDSDRO23S44 EB 20140407 101,808 101,797
DK0009789570 1120578 3NYKE DA44 20140407 96,988 96,990
DK0009785826 1381076 3NYKI A44 20140407 96,703 96,703
DK0009922676 774220 3St.l. 21 GB 20140407 113,003 113,003
DK0009270233 4827 4D23Ds 35 20140407 106,517 106,518
DK0009270233 73360 4D23Ds 35 EB 20140407 106,517 106,518
DK0009921439 7435 4St.l.15 GB 20140407 126,550 106,315
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 34

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 497

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 17

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 81

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 62

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 493

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

FPI Earnings Preview: Traders Eye EPS and Guidance Impact

Updated Category News Views 158

Farmland Partners (NYSE:FPI) is prepped to drop its quarterly earnings on February 18, 2026, and you better believe traders are already sweating over it. Analysts are throwing out estimates pegging the earnings per share (EPS) at $0.19—now, that's not exactly a home run but it's enough to keep eyes glued to the screens as we await the news. The buzz in the air is thick;...

Continue Reading
Reviva Pharmaceuticals Engages Investors at 2025 Summit

Updated Category News Views 312

Reviva Pharmaceuticals Attending the 2025 Investor Healthcare Summit Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a leader in the biopharmaceutical industry, committed to developing cutting-edge therapies that cater to unmet medical needs. This January, Reviva will have an influential presence at the upcoming Lytham Partners 2025 Investor Healthcare Summit....

Continue Reading
Genpact's Q1 2025 Financial Highlights and Future Outlook

Updated Category News Views 886

Financial Performance Overview for Genpact Genpact Limited (NYSE: G) has reported outstanding net revenues of $1.215 billion for the first quarter of 2025, reflecting a robust growth rate of 7.4% year-over-year, or 8.3% when adjusted for constant currency fluctuations. This growth has been fueled by an impressive performance in its Data-Tech-AI segment, which generated...

Continue Reading
Multinational Investments: How to Reach More Countries

Updated Category Investing Views 706

Global expansion has become a strategic priority for companies seeking long-term growth. Markets mature, local competition intensifies, and consumer expectations evolve quickly. As a result, multinational investments are no longer reserved for massive corporations. Mid-sized and even smaller firms are exploring foreign markets to diversify revenue and increase resilience....

Continue Reading
Nobu Hospitality Unveils Luxury Residential Options in Kraków

Updated Category News Views 126

Nobu Hospitality Expands Its Luxury Footprint Nobu Hospitality is a name synonymous with luxury and refinement in the hospitality industry, expanding its prestigious brand into new territories. One of its latest ventures takes a significant leap into a magnificent city rich in history—Kraków. This development marks a notable milestone as it is Nobu's first residential...

Continue Reading